I've now dumped my Realty Income position on my head in order to increase my $ABBV (-1,8%) position to 10 shares. I expect AbbVie to perform better than the Reit over the next few years.
Sales will probably continue to be driven up mainly by Rinvoq and Skyrizi. I'm slightly biased because I'm a Skyrizi patient myself, but objectively I think it looks good thanks to all the new approvals for other diagnoses.
AbbVie to the Mooon :)
